Suppression of an Antibody to Factor VIII by a Combination of Factor VIII and Cyclophosphamide

Author:

GREEN DAVID12

Affiliation:

1. Hematology Section, Department of Medicine, Northwestern University Medical School, Chicago, Ill.

2. Hematology Section, Department of Medicine, Northwestern University Medical School, Chicago, Ill.; holder of a grant from the Schweppe Foundation.

Abstract

Abstract A 54-year-old woman with a 20-year history of generalized, severe psoriasis presented with diffuse ecchymoses, melena, and vaginal bleeding. The whole blood clotting time was 59 minutes and the plasma factor VIII concentration was less than 1 per cent of normal. Incubation of the patient’s plasma with cryoprecipitate containing one unit of factor VIII resulted in the rapid disappearance of factor VIII activity from the mixture. The major antifactor VIII activity of the patient’s plasma was associated with an immunoglobulin of the IgG class. The patient was initially treated with a combination of methotrexate, azathioprine, and cyclophosphamide. No improvement occurred, and after 6 weeks of therapy the drugs were discontinued. Eight months later, she presented with an expanding sublingual hematoma. Bleeding was controlled by the rapid administration of 10,000 units of factor VIII, and an intravenous dose of cyclophosphamide given concurrently resulted in a prompt decline in antibody titer. Factor VIII levels subsequently became normal and have remained normal during 7 months of follow-up observation.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Guidelines for the management of acquired hemophilia A: 2017 revision;Japanese Journal of Thrombosis and Hemostasis;2017

2. Treatment Options for Acquired Hemophilia;Hemostasis and Thrombosis;2014-02-14

3. Acquired hemophilia eclipsed by psoriatic arthralgia;The Journal of Dermatology;2013-12

4. Acquired haemophilia A: A 2013 update;Thrombosis and Haemostasis;2013

5. Acquired Inhibitors of Coagulation Factors: Part I—Acquired Hemophilia A;Seminars in Thrombosis and Hemostasis;2012-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3